COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02015351
Recruitment Status : Unknown
Verified December 2013 by Joyce Hisae Yamamoto, University of Sao Paulo.
Recruitment status was:  Active, not recruiting
First Posted : December 19, 2013
Last Update Posted : December 19, 2013
Fundação de Amparo à Pesquisa do Estado de São Paulo
Information provided by (Responsible Party):
Joyce Hisae Yamamoto, University of Sao Paulo

No Study Results Posted on for this Study
Recruitment Status : Unknown
Actual Primary Completion Date : October 2013
Estimated Study Completion Date : June 2014
Publications of Results: